Related references
Note: Only part of the references are listed.Diagnostic accuracy of immunofluorescence versus immunoperoxidase staining to distinguish immune complex-mediated glomerulonephritis and C3 dominant glomerulopathy
Yassine Bouatou et al.
HISTOPATHOLOGY (2018)
Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy
Moglie Le Quintrec et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series
Rupali S. Avasare et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy
Amy J. Osborne et al.
JOURNAL OF IMMUNOLOGY (2018)
C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy
Andrew S. Bomback et al.
KIDNEY INTERNATIONAL (2018)
C3 glomerulopathy associated with monoclonal Ig is a distinct subtype
Aishwarya Ravindran et al.
KIDNEY INTERNATIONAL (2018)
Complement biomarkers as predictors of disease outcome in C3 glomerulopathy
Jill Hauer et al.
MOLECULAR IMMUNOLOGY (2018)
C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic
Aishwarya Ravindran et al.
MAYO CLINIC PROCEEDINGS (2018)
Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN
Maria Chiara Marinozzi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
A proposal for standardized grading of chronic changes in native kidney biopsy specimens
Sanjeev Sethi et al.
KIDNEY INTERNATIONAL (2017)
A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy
Shambhuprasad K. Togarsimalemath et al.
KIDNEY INTERNATIONAL (2017)
C5 nephritic factors drive the biological phenotype of C3 glomerulopathies
Maria-Chiara Marinozzi et al.
KIDNEY INTERNATIONAL (2017)
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Timothy H. J. Goodship et al.
KIDNEY INTERNATIONAL (2017)
Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis
Sanjeev Sethi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
C4 Nephritic Factors in C3 Glomerulopathy: A Case Series
Yuzhou Zhang et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2017)
Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy
Sophie Chauvet et al.
BLOOD (2017)
Visualization of the glomerular endothelial glycocalyx by electron microscopy using cationic colloidal thorium dioxide
Jan Hegermann et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2016)
High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies
Fengxiao Bu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Complement Factor H-Related 5-Hybrid Proteins Anchor Properdin and Activate Complement at Self-Surfaces
Qian Chen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
The complement factor H-related proteins
Nicholas Medjeral-Thomas et al.
IMMUNOLOGICAL REVIEWS (2016)
Properdin: a tightly regulated critical inflammatory modulator
Adam Z. Blatt et al.
IMMUNOLOGICAL REVIEWS (2016)
Complement component C3-The Swiss Army Knife of innate immunity and host defense
Daniel Ricklin et al.
IMMUNOLOGICAL REVIEWS (2016)
Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro
Markus A. Loeven et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis
Anna M. Blom et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2016)
Complement receptor 3 mediates renal protection in experimental C3 glomerulopathy
Thomas D. Barbour et al.
KIDNEY INTERNATIONAL (2016)
Familial C3 glomerulonephritis caused by a novel CFHR5-CFHR2 fusion gene
Xue Xiao et al.
MOLECULAR IMMUNOLOGY (2016)
Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome
Paraskevas Iatropoulos et al.
MOLECULAR IMMUNOLOGY (2016)
Complement inhibition in C3 glomerulopathy
Carla M. Nester et al.
SEMINARS IN IMMUNOLOGY (2016)
C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome
Isaac E. Lloyd et al.
CLINICAL KIDNEY JOURNAL (2016)
Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy
Mazdak A. Khalighi et al.
CLINICAL KIDNEY JOURNAL (2016)
Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015
Marina Noris et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Anti-Factor H Autoantibodies in C3 Glomerulopathies and in Atypical Hemolytic Uremic Syndrome: One Target, Two Diseases
Caroline Blanc et al.
JOURNAL OF IMMUNOLOGY (2015)
Factor H-Related Protein 5 Interacts with Pentraxin 3 and the Extracellular Matrix and Modulates Complement Activation
Adam I. Csincsi et al.
JOURNAL OF IMMUNOLOGY (2015)
Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach
An S. De Vriese et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
Cristina Rabasco et al.
KIDNEY INTERNATIONAL (2015)
Factor H-related proteins determine complement-activating surfaces
Mihaly Jozsi et al.
TRENDS IN IMMUNOLOGY (2015)
C3 Glomerulopathy: Clinicopathologic Features and Predictors of Outcome
Nicholas R. Medjeral-Thomas et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Complement factor H related hybrid protein deregulates complement in dense deposit disease
Qian Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Clinical Findings, Pathology, and Outcomes of C3GN after Kidney Transplantation
Ladan Zand et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Global Analysis Reveals the Complexity of the Human Glomerular Extracellular Matrix
Rachel Lennon et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Toward a working definition of C3 glomerulopathy by immunofluorescence
Jean Hou et al.
KIDNEY INTERNATIONAL (2014)
Resolution of the three dimensional structure of components of the glomerular filtration barrier
Kenton P. Arkill et al.
BMC NEPHROLOGY (2014)
C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation
Agustin Tortajada et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Combination of Factor H Mutation and Properdin Deficiency Causes Severe C3 Glomerulonephritis
Allison M. Lesher et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Loss of Properdin Exacerbates C3 Glomerulopathy Resulting from Factor H Deficiency
Marieta M. Ruseva et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
C3 glomerulopathy: consensus report
Matthew C. Pickering et al.
KIDNEY INTERNATIONAL (2013)
Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement
Sanjeev Sethi et al.
KIDNEY INTERNATIONAL (2013)
Dimerization of complement factor H-related proteins modulates complement activation in vivo
Elena Goicoechea de Jorge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Causes of Alternative Pathway Dysregulation in Dense Deposit Disease
Yuzhou Zhang et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis
Andrew S. Bomback et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
A Hybrid CFHR3-1 Gene Causes Familial C3 Glomerulopathy
Talat H. Malik et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
C3 glomerulopathy: what's in a name?
Vivette D. D'Agati et al.
KIDNEY INTERNATIONAL (2012)
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
Aude Servais et al.
KIDNEY INTERNATIONAL (2012)
Membranoproliferative Glomerulonephritis - A New Look at an Old Entity
Sanjeev Sethi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Clinical features and outcomes of 98 children and adults with dense deposit disease
Der-Fa Lu et al.
PEDIATRIC NEPHROLOGY (2012)
Allograft Failure in Kidney Transplant Recipients With Membranoproliferative Glomerulonephritis
Joseph R. Angelo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Familial C3 Glomerulopathy Associated with CFHR5 Mutations: Clinical Characteristics of 91 Patients in 16 Pedigrees
Yiannis Athanasiou et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis
Daniel P. Gale et al.
LANCET (2010)
Anti-factor B autoantibody in dense deposit disease
Stefanie Strobel et al.
MOLECULAR IMMUNOLOGY (2010)
Structure of the Extracellular Portion of CD46 Provides Insights into Its Interactions with Complement Proteins and Pathogens
B. David Persson et al.
PLOS PATHOGENS (2010)
Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation
Stefan Heinen et al.
BLOOD (2009)
Dense Deposit Disease: Clinicopathologic Study of 32 Pediatric and Adult Patients
Samih H. Nasr et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway
Sanjeev Sethi et al.
KIDNEY INTERNATIONAL (2009)
Structure of complement fragment C3b-factor H and implications for host protection by complement regulators
Jin Wu et al.
NATURE IMMUNOLOGY (2009)
Primary glomerulonephritis with isolated C3 deposits:: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome
Aude Servais et al.
JOURNAL OF MEDICAL GENETICS (2007)
New approaches to the treatment of dense deposit disease
Richard J. H. Smith et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Prevention of C5 activation ameliorates spontaneous and experimental factor H-deficient glomerulonephritis in mice
M. C. Pickering et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15
C Licht et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
HMG-CoA reductase inhibitors for the prevention of nephropathy
NM Maisch et al.
ANNALS OF PHARMACOTHERAPY (2004)
Hyperlipidemia and thrombotic complications in patients with membranous nephropathy
TL Nickolas et al.
SEMINARS IN NEPHROLOGY (2003)
Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H
MC Pickering et al.
NATURE GENETICS (2002)
Share Paper
